Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Mammographic Breast Density and Breast Cancer Molecular Subtypes: The Kenyan-African Aspect

Domaine:

healthcare
Créateur:
AsiMaeShaRos
Éditeur:
WILEY
Hôte:
Introduction. Data examining mammographic breast density (MBD) among patients in Sub-Saharan Africa are sparse. We evaluated how MBD relates to breast cancer characteristics in Kenyan women undergoing diagnostic mammography. Methods. This cross-sectional study included women with pathologically confirmed breast cancers ( n = 123 ). Pretreatment mammograms of the unaffected breast were assessed to estimate absolute dense area (cm 2 ), nondense area (cm 2 ), and percent density (PD). Relationships between density measurements and clinical characteristics were evaluated using analysis of covariance. Results. Median PD and dense area were 24.9% and 85.3 cm 2 . Higher PD and dense area were observed in younger women ( P < 0.01 ). Higher dense and nondense areas were observed in obese women ( P -trend < 0.01). Estrogen receptor (ER) positive patients (73%) had higher PD and dense area than ER-negative patients ( P ≤ 0.02 ). Triple negative breast cancer (TNBC) patients (17%) had lower PD and dense area ( P ≤ 0.01 ) compared with non-TNBCs. No associations were observed between MBD and tumor size and grade. Conclusions. Our findings show discordant relationships between MBD and molecular tumor subtypes to those previously observed in Western populations. The relatively low breast density observed at diagnosis may have important implications for cancer prevention initiatives in Kenya. Subsequent larger studies are needed to confirm these findings.

Visit

doi.org

Licenses

http://creativecommons.org/licenses/by/4.0/

Similaires

Breast cancer in Angola, molecular subtypes: The first preliminary study.Molecular Subtypes of Receptor-defined Breast Cancer from Nakuru, KenyaPredictors of molecular subtypes in women with breast cancer in RwandaAbstract B070: Characterizing breast cancer etiologic subtypes in the Ghana Breast Health StudyPremenopausal Breast Cancer Risk Factors and Associations with Molecular Subtypes: A Case-Control StudyMolecular subtypes of breast cancer in Jamaican women: high prevalence of triple-negative and HER2 + disease

Breast cancer in Angola, molecular subtypes: The first preliminary study.

e13075 Background: Women in sub-Saharan African countries, as Angola, are experiencing an increas

Molecular Subtypes of Receptor-defined Breast Cancer from Nakuru, Kenya

Introduction The incidence of breast cancer in Sub-Saharan-Africa (SSA) is rising. Expression of h

Predictors of molecular subtypes in women with breast cancer in Rwanda

INTRODUCTION: Breast cancer (BC) constitutes a major public health problem worldwide. It remains a m

Abstract B070: Characterizing breast cancer etiologic subtypes in the Ghana Breast Health Study

Abstract Background: Breast cancer subtyping has largely been based on immunohistoc

Premenopausal Breast Cancer Risk Factors and Associations with Molecular Subtypes: A Case-Control Study

Background. Breast cancer (BC) is the most prevalent cancer in women and the leading cause of women’

Molecular subtypes of breast cancer in Jamaican women: high prevalence of triple-negative and HER2 + disease

Abstract Background Breast cancer incidence and mortality patterns vary significantly across populat